# Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma

> **NCT03825302** · — · WITHDRAWN · sponsor: **Vanderbilt University Medical Center**

## Conditions studied

- Asthma

## Interventions

- **DIAGNOSTIC_TEST:** Methacholine challenge
- **DIAGNOSTIC_TEST:** Mannitol challenge

## Key facts

- **NCT ID:** NCT03825302
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-12-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding available.
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03825302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03825302, "Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03825302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*